Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Stock Now Rated "Hold" by Wall Street Analysts

Key Points

• Acadia Healthcare has a consensus “Hold” rating among 15 analysts: eight recommend buying, five recommend holding, and two recommend selling. The average 12-month price target is $30.69.
• Several firms recently raised their price targets and maintained positive ratings, including KeyCorp’s $40 target, Guggenheim’s $39 target, and TD Cowen’s $36 target.
• ACHC opened at $29.96, with a $2.79 billion market capitalization and a 52-week range of $11.43 to $35.83. Institutional investors including Prescott Group and Congress Asset Management increased their positions.

Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report) has been assigned a consensus recommendation of "Hold" from the fifteen brokerages that are currently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, five have assigned a hold recommendation and eight have assigned a buy recommendation to the company. The average 12 month target price among brokers that have issued a report on the stock in the last year is $30.69.

A number of research analysts have weighed in on the stock. TD Cowen boosted their target price on shares of Acadia Healthcare from $30.00 to $36.00 and gave the company a "buy" rating in a research note on Tuesday, July 14th. Weiss Ratings reaffirmed a "sell (d)" rating on shares of Acadia Healthcare in a research report on Wednesday, September 9th. Guggenheim upped their price target on Acadia Healthcare from $38.00 to $39.00 and gave the stock a "buy" rating in a research note on Thursday, July 30th. UBS Group lifted their price objective on Acadia Healthcare from $31.00 to $39.00 and gave the stock a "buy" rating in a research report on Thursday, July 9th. Finally, KeyCorp upped their price objective on Acadia Healthcare from $30.00 to $40.00 and gave the company an "overweight" rating in a report on Tuesday, July 14th.

Acadia Healthcare Price Performance

NASDAQ:ACHC opened at $29.96 on Monday. The firm has a market capitalization of $2.79 billion, a price-to-earnings ratio of -2.41, a PEG ratio of 9.65 and a beta of 0.63. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.57 and a quick ratio of 1.57. Acadia Healthcare has a 1 year low of $11.43 and a 1 year high of $35.83. The business has a 50 day simple moving average of $29.08 and a 200-day simple moving average of $25.64.

Institutional Investors Weigh In On Acadia Healthcare

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Prescott Group Capital Management L.L.C. lifted its position in shares of Acadia Healthcare by 40.0% in the 3rd quarter. Prescott Group Capital Management L.L.C. now owns 70,000 shares of the company's stock worth $1,925,000 after purchasing an additional 20,000 shares during the period. Pinnacle Wealth Planning Services Inc. raised its holdings in shares of Acadia Healthcare by 20.7% in the third quarter. Pinnacle Wealth Planning Services Inc. now owns 3,209 shares of the company's stock valued at $88,000 after buying an additional 550 shares during the last quarter. Congress Asset Management Co. grew its position in shares of Acadia Healthcare by 20.8% during the 3rd quarter. Congress Asset Management Co. now owns 287,390 shares of the company's stock worth $7,903,000 after purchasing an additional 49,418 shares in the last quarter. WINTON GROUP Ltd grew its holdings in Acadia Healthcare by 1.4% during the second quarter. WINTON GROUP Ltd now owns 255,451 shares of the company's stock worth $7,543,000 after buying an additional 3,449 shares in the last quarter. Finally, Integrated Wealth Concepts LLC bought a new stake in Acadia Healthcare in the 2nd quarter worth $79,000.

About Acadia Healthcare

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services headquartered in Franklin, Tennessee. The company operates psychiatric hospitals, specialty treatment facilities and outpatient programs focused on mental health and substance use disorders.

Acadia's services include inpatient and outpatient psychiatric care, addiction treatment, residential treatment, eating-disorder programs, and services for children and adolescents. Its facilities serve patients with a range of behavioral health conditions, including depression, anxiety, trauma-related disorders and substance use disorders.

Founded in 2005, Acadia operates primarily in the United States and also has a significant presence in the United Kingdom through its ownership of Priory, a behavioral healthcare provider.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.